Connecting Malfunctioning Glial Cells and Brain Degenerative Disorders

Genomics, Proteomics and Bioinformatics

Volumn 14, Issue 3, 2016, Pages 155-165

  Kaminsky, Natalie ^a   Bihari, Ofer ^a   Kanner, Sivan ^a   Barzilai, Ari ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Astrocytes; Brain degenerative diseases; DNA damage response; Genomic instability; Glial cells; Microglia

Indexed keywords

ATM PROTEIN; DNA; NIBRIN; CELL CYCLE PROTEIN;

ASTROCYTE; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DEGENERATIVE DISEASE; DNA DAMAGE; DNA DAMAGE RESPONSE; GENOMIC INSTABILITY; GLIA CELL; HOMEOSTASIS; HUMAN; MICROGLIA; NERVE CELL CHARACTERISTICS AND FUNCTIONS; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIMARY CULTURE; PROTEIN DEPLETION; REVIEW; ANIMAL; CYTOLOGY; DEFICIENCY; DNA REPAIR; GENETICS; GLIA; METABOLISM; PATHOLOGY;

ANIMALS; ASTROCYTES; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGLIA;

EID: 84973560661     PISSN: 16720229     EISSN: 22103244     Source Type: Journal    
DOI: 10.1016/j.gpb.2016.04.003     Document Type: Review

References (120)

1. [1] Cadet, J., Wagner, J.R., DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol, 5, 2013, a012559.
2. [2] Lindahl, T., Instability and decay of the primary structure of DNA. Nature 362 (1993), 709–715.
3. [3] Vijg, J., Suh, Y., Genome instability and aging. Annu Rev Physiol 75 (2013), 645–668.
4. [4] Abbas, T., Keaton, M.A., Dutta, A., Genomic instability in cancer. Cold Spring Harb Perspect Biol, 5, 2013, a012914.
5. [5] Ciccia, A., Elledge, S.J., The DNA damage response: making it safe to play with knives. Mol Cell 40 (2010), 179–204.
6. [6] Sirbu, B.M., Cortez, D., DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol, 5, 2013, a012724.
7. [7] Thompson, L.H., Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat Res 751 (2012), 158–246.
8. [8] Shiloh, Y., Ziv, Y., The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14 (2013), 197–210.
9. [9] McKinnon, P.J., Maintaining genome stability in the nervous system. Nat Neurosci 16 (2013), 1523–1529.
10. [10] O'Driscoll, M., Diseases associated with defective responses to DNA damage. Cold Spring Harb Perspect Biol, 4, 2012, a012773.
11. [11] Roy, R., Chun, J., Powell, S.N., BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer 12 (2011), 68–78.
12. [12] Sorrell, A.D., Espenschied, C.R., Culver, J.O., Weitzel, J.N., Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther 17 (2013), 31–47.
13. [13] Pena-Diaz, J., Jiricny, J., Mammalian mismatch repair: error-free or error-prone?. Trends Biochem Sci 37 (2012), 206–214.
14. [14] Negrini, S., Gorgoulis, V.G., Halazonetis, T.D., Genomic instability – an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11 (2010), 220–228.
15. [15] Shimizu, I., Yoshida, Y., Suda, M., Minamino, T., DNA damage response and metabolic disease. Cell Metab 20 (2014), 967–977.
16. [16] Ishida, T., Ishida, M., Tashiro, S., Yoshizumi, M., Kihara, Y., Role of DNA damage in cardiovascular disease. Circ J 78 (2014), 42–50.
17. [17] Shiloh, Y., ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3 (2003), 155–168.
18. [18] Shiloh, Y., ATM: expanding roles as a chief guardian of genome stability. Exp Cell Res 329 (2014), 154–161.
19. [19] Taylor, A.M., Groom, A., Byrd, P.J., Ataxia-telangiectasia-like disorder (ATLD) – its clinical presentation and molecular basis. DNA Repair (Amsterdam) 3 (2004), 1219–1225.
20. [20] O'Driscoll, M., Gennery, A.R., Seidel, J., Concannon, P., Jeggo, P.A., An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amsterdam) 3 (2004), 1227–1235.
21. [21] Chrzanowska, K.H., Gregorek, H., Dembowska-Baginska, B., Kalina, M.A., Digweed, M., Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis, 7, 2012, 13.
22. [22] Stewart, G.S., Maser, R.S., Stankovic, T., Bressan, D.A., Kaplan, M.I., Jaspers, N.G., et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99 (1999), 577–587.
23. [23] Uziel, T., Lerenthal, Y., Moyal, L., Andegeko, Y., Mittelman, L., Shiloh, Y., Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22 (2003), 5612–5621.
24. [24] Digweed, M., Sperling, K., Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amsterdam) 3 (2004), 1207–1217.
25. [25] Lavin, M.F., Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9 (2008), 759–769.
26. [26] Stracker, T.H., Petrini, J.H., The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol 12 (2011), 90–103.
27. [27] Chrzanowska, K.H., Kleijer, W.J., Krajewska-Walasek, M., Bialecka, M., Gutkowska, A., Goryluk-Kozakiewicz, B., et al. Eleven Polish patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am J Med Genet 57 (1995), 462–471.
28. [28] Assaf, Y., Galron, R., Shapira, I., Nitzan, A., Blumenfeld-Katzir, T., Solomon, A.S., et al. MRI evidence of white matter damage in a mouse model of Nijmegen breakage syndrome. Exp Neurol 209 (2008), 181–191.
29. [29] Cabana, M.D., Crawford, T.O., Winkelstein, J.A., Christensen, J.R., Lederman, H.M., Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics 102 (1998), 98–100.
30. [30] Crawford, T.O., Mandir, A.S., Lefton-Greif, M.A., Goodman, S.N., Goodman, B.K., Sengul, H., et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 54 (2000), 1505–1509.
31. [31] Palazzo, L., Della Monica, R., Visconti, R., Costanzo, V., Grieco, D., ATM controls proper mitotic spindle structure. Cell Cycle 13 (2014), 1091–1100.
32. [32] Crawford, T.O., Ataxia telangiectasia. Semin Pediatr Neurol 5 (1998), 287–294.
33. [33] Lefton-Greif, M.A., Crawford, T.O., Winkelstein, J.A., Loughlin, G.M., Koerner, C.B., Zahurak, M., et al. Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia. J Pediatr 136 (2000), 225–231.
34. [34] Gatti, R.A., Vinters, H.V., Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 19 (1985), 225–232.
35. [35] Chun, H.H., Gatti, R.A., Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amsterdam) 3 (2004), 1187–1196.
36. [36] Shiloh, Y., Ataxia-telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 3 (1995), 116–138.
37. [37] Li, J., Han, Y.R., Plummer, M.R., Herrup, K., Cytoplasmic ATM in neurons modulates synaptic function. Curr Biol 19 (2009), 2091–2096.
38. [38] Greengard, P., Benfenati, F., Valtorta, F., Synapsin, I., An actin-binding protein regulating synaptic vesicle traffic in the nerve terminal. Adv Second Messenger Phosphoprotein Res 29 (1994), 31–45.
39. [39] Park, H.J., Friston, K., Structural and functional brain networks: from connections to cognition. Science, 342, 2013, 1238411.
40. [40] Levine-Small, N., Yekutieli, Z., Aljadeff, J., Boccaletti, S., Ben-Jacob, E., Barzilai, A., Reduced synchronization persistence in neural networks derived from atm-deficient mice. Front Neurosci, 5, 2011, 46.
41. [41] Chiesa, N., Barlow, C., Wynshaw-Boris, A., Strata, P., Tempia, F., Atm-deficient mice Purkinje cells show age-dependent defects in calcium spike bursts and calcium currents. Neuroscience 96 (2000), 575–583.
42. [42] Przedborski, S., Pahan, K., Kipnis, J., Kabanov, A., Ikexu, T., Gendelman, H.E., (eds.) Neuroimmune pharmacology, 2008, Springer, New York, 1–793.
43. [43] Raz-Prag, D., Galron, R., Segev-Amzaleg, N., Solomon, A.S., Shiloh, Y., Barzilai, A., et al. A role for vascular deficiency in retinal pathology in a mouse model of ataxia-telangiectasia. Am J Pathol 179 (2011), 1533–1541.
44. [44] Meshulam, L., Galron, R., Kanner, S., De Pitta, M., Bonifazi, P., Goldin, M., et al. The role of the neuro-astro-vascular unit in the etiology of ataxia telangiectasia. Front Pharmacol, 3, 2012, 157.
45. [45] Barzilai, A., The interrelations between malfunctioning DNA damage response (DDR) and the functionality of the neuro-glio-vascular unit. DNA Repair (Amsterdam) 12 (2013), 543–557.
46. [46] Frappart, P.O., Lee, Y., Russell, H.R., Chalhoub, N., Wang, Y.D., Orii, K.E., et al. Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency. Proc Natl Acad Sci U S A 106 (2009), 1880–1885.
47. [47] Galron, R., Gruber, R., Lifshitz, V., Lu, H., Kirshner, M., Ziv, N., et al. Astrocyte dysfunction associated with cerebellar attrition in a Nijmegen breakage syndrome animal model. J Mol Neurosci 45 (2011), 202–211.
48. [48] Exner, S., Entwurf zur physiologischen Erkla¨rung der Psychischen Erscheinungen. 1894, Deiticke, Leipzig/Vienna.
49. [49] Ramon y Cajal, S., Histologie du systeme nerveux de l'homme et des vertebres. 1909, Masson, Paris.
50. [50] Barzilai, A., Biton, S., Shiloh, Y., The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amsterdam) 7 (2008), 1010–1027.
51. [51] Oberheim, N.A., Wang, X., Goldman, S., Nedergaard, M., Astrocytic complexity distinguishes the human brain. Trends Neurosci 29 (2006), 547–553.
52. [52] Oberheim, N.A., Takano, T., Han, X., He, W., Lin, J.H., Wang, F., et al. Uniquely hominid features of adult human astrocytes. J Neurosci 29 (2009), 3276–3287.
53. [53] Haydon, P.G., Carmignoto, G., Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86 (2006), 1009–1031.
54. [54] Giaume, C., Kirchhoff, F., Matute, C., Reichenbach, A., Verkhratsky, A., Glia: the fulcrum of brain diseases. Cell Death Differ 14 (2007), 1324–1335.
55. [55] Buffo, A., Rite, I., Tripathi, P., Lepier, A., Colak, D., Horn, A.P., et al. Origin and progeny of reactive gliosis: a source of multipotent cells in the injured brain. Proc Natl Acad Sci U S A 105 (2008), 3581–3586.
56. [56] Perea, G., Navarrete, M., Araque, A., Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32 (2009), 421–431.
57. [57] Sofroniew, M.V., Vinters, H.V., Astrocytes: biology and pathology. Acta Neuropathol 119 (2010), 7–35.
58. [58] Barzilai, A., The neuro-glial-vascular interrelations in genomic instability symptoms. Mech Ageing Dev 132 (2011), 395–404.
59. [59] Heneka, M.T., Rodriguez, J.J., Verkhratsky, A., Neuroglia in neurodegeneration. Brain Res Rev 63 (2010), 189–211.
60. [60] Abbott, N.J., Ronnback, L., Hansson, E., Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7 (2006), 41–53.
61. [61] Anderson, C.M., Nedergaard, M., Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci 26 (2003), 340–344 author reply 344–5.
62. [62] De Keyser, J., Zeinstra, E., Frohman, E., Are astrocytes central players in the pathophysiology of multiple sclerosis?. Arch Neurol 60 (2003), 132–136.
63. [63] Dong, Y., Benveniste, E.N., Immune function of astrocytes. Glia 36 (2001), 180–190.
64. [64] Gordon, G.R., Mulligan, S.J., MacVicar, B.A., Astrocyte control of the cerebrovasculature. Glia 55 (2007), 1214–1221.
65. [65] Haydon, P.G., GLIA: listening and talking to the synapse. Nat Rev Neurosci 2 (2001), 185–193.
66. [66] Ke, C., Poon, W.S., Ng, H.K., Pang, J.C., Chan, Y., Heterogeneous responses of aquaporin-4 in oedema formation in a replicated severe traumatic brain injury model in rats. Neurosci Lett 301 (2001), 21–24.
67. [67] Nase, G., Helm, P.J., Enger, R., Ottersen, O.P., Water entry into astrocytes during brain edema formation. Glia 56 (2008), 895–902.
68. [68] Nedergaard, M., Ransom, B., Goldman, S.A., New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26 (2003), 523–530.
69. [69] Nedergaard, M., Verkhratsky, A., Artifact versus reality – how astrocytes contribute to synaptic events. Glia 60 (2012), 1013–1023.
70. [70] Risher, W.C., Andrew, R.D., Kirov, S.A., Real-time passive volume responses of astrocytes to acute osmotic and ischemic stress in cortical slices and in vivo revealed by two-photon microscopy. Glia 57 (2009), 207–221.
71. [71] Stevens, B., Neuron-astrocyte signaling in the development and plasticity of neural circuits. Neurosignals 16 (2008), 278–288.
72. [72] Verkhratsky, A., Parpura, V., Pekna, M., Pekny, M., Sofroniew, M., Glia in the pathogenesis of neurodegenerative diseases. Biochem Soc Trans 42 (2014), 1291–1301.
73. [73] Zonta, M., Angulo, M.C., Gobbo, S., Rosengarten, B., Hossmann, K.A., Pozzan, T., et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6 (2003), 43–50.
74. [74] Liu, S., Yin, F., Zhang, J., Qian, Y., The role of calpains in traumatic brain injury. Brain Inj 28 (2014), 133–137.
75. [75] Guček, A., Vardjan, N., Zorec, R., Exocytosis in astrocytes: transmitter release and membrane signal regulation. Neurochem Res 37 (2012), 2351–2363.
76. [76] Kreft, M., Stenovec, M., Rupnik, M., Grilc, S., Krzan, M., Potokar, M., et al. Properties of Ca(2+)-dependent exocytosis in cultured astrocytes. Glia 46 (2004), 437–445.
77. [77] Osborne, K.D., Lee, W., Malarkey, E.B., Irving, A.J., Parpura, V., Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes. ASN Neuro, 1, 2009, e00022.
78. [78] Parpura, V., Grubišić, V., Verkhratsky, A., Ca(2+) sources for the exocytotic release of glutamate from astrocytes. Biochim Biophys Acta 1813 (2011), 984–991.
79. [79] Parpura, V., Heneka, M.T., Montana, V., Oliet, S.H., Schousboe, A., Haydon, P.G., et al. Glial cells in (patho)physiology. J Neurochem 121 (2012), 4–27.
80. [80] Parpura, V., Zorec, R., Gliotransmission: exocytotic release from astrocytes. Brain Res Rev 63 (2010), 83–92.
81. 2+ as a signalling route. ASN Neuro, 4, 2012, e00080.
82. [82] van Leeuwen, L.A., Hoozemans, J.J., Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease. Acta Neuropathol 129 (2015), 511–525.
83. [83] Ge, W.P., Jia, J.M., Local production of astrocytes in the cerebral cortex. Neuroscience 323 (2016), 3–9.
84. [84] Adams, B.R., Golding, S.E., Rao, R.R., Valerie, K., Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS One, 5, 2010, e10001.
85. [85] Schneider, L., Fumagalli, M., d'Adda di Fagagna, F., Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency. Cell Death Differ 19 (2012), 582–591.
86. [86] Short, S.C., Giampieri, S., Worku, M., Alcaide-German, M., Sioftanos, G., Bourne, S., et al. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol 13 (2011), 487–499.
87. [87] Fluteau, A., Ince, P.G., Minett, T., Matthews, F.E., Brayne, C., Garwood, C.J., et al. The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain. Neurosci Lett 609 (2015), 11–17.
88. [88] Yong, R.L., Yang, C., Lu, J., Wang, H., Schlaff, C.D., Tandle, A., et al. Cell transcriptional state alters genomic patterns of DNA double-strand break repair in human astrocytes. Nat Commun, 5, 2014, 5799.
89. [89] Swain, U., Subba, Rao K., Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging. Mech Ageing Dev 132 (2011), 374–381.
90. [90] McEllin, B., Camacho, C.V., Mukherjee, B., Hahm, B., Tomimatsu, N., Bachoo, R.M., et al. PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. Cancer Res 70 (2010), 5457–5464.
91. [91] Del RioHortega, P., El, tercer elemento de los centros nerviosis. Bol Soc Esp Biol 9 (1919), 69–129.
92. [92] Liu, B., Hong, J.S., Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 (2003), 1–7.
93. [93] Kawabori, M., Yenari, M.A., The role of the microglia in acute CNS injury. Metab Brain Dis 30 (2015), 381–392.
94. [94] Stence, N., Waite, M., Dailey, M.E., Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia 33 (2001), 256–266.
95. [95] Perry, V.H., Nicoll, J.A., Holmes, C., Microglia in neurodegenerative disease. Nat Rev Neurol 6 (2010), 193–201.
96. [96] Ransohoff, R.M., Cardona, A.E., The myeloid cells of the central nervous system parenchyma. Nature 468 (2010), 253–262.
97. [97] Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
98. [98] Ribeiro Xavier, A.L., Kress, B.T., Goldman, S.A., Lacerda de Menezes, J.R., Nedergaard, M.A., Distinct population of microglia supports adult neurogenesis in the subventricular zone. J Neurosci 35 (2015), 11848–11861.
99. [99] Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333 (2011), 1456–1458.
100. [100] Ledoux, S.P., Shen, C.C., Grishko, V.I., Fields, P.A., Gard, A.L., Wilson, G.L., Glial cell-specific differences in response to alkylation damage. Glia 24 (1998), 304–312.
101. [101] Sheng, Z., Oka, S., Tsuchimoto, D., Abolhassani, N., Nomaru, H., Sakumi, K., et al. 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J Clin Invest 122 (2012), 4344–4361.
102. [102] Perry, V.H., Holmes, C., Microglial priming in neurodegenerative disease. Nat Rev Neurol 10 (2014), 217–224.
103. [103] Raj, D.D., Jaarsma, D., Holtman, I.R., Olah, M., Ferreira, F.M., Schaafsma, W., et al. Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol Aging 35 (2014), 2147–2160.
104. [104] Kennedy, B.P., Bottiglieri, T., Arning, E., Ziegler, M.G., Hansen, L.A., Masliah, E., Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm (Vienna) 111 (2004), 547–567.
105. [105] Liu, C.C., Ho, W.Y., Leu, K.L., Tsai, H.M., Yang, T.H., Effects of S-adenosylhomocysteine and homocysteine on DNA damage and cell cytotoxicity in murine hepatic and microglia cell lines. J Biochem Mol Toxicol 23 (2009), 349–356.
106. [106] Lin, H.C., Song, T.Y., Hu, M.L., S-adenosylhomocysteine enhances DNA damage through increased beta-amyloid formation and inhibition of the DNA-repair enzyme OGG1b in microglial BV-2 cells. Toxicology 290 (2011), 342–349.
107. [107] Pomponio, R., Gotti, R., Santagati, N.A., Cavrini, V., Analysis of catechins in extracts of Cistus species by microemulsion electrokinetic chromatography. J Chromatogr A 990 (2003), 215–223.
108. [108] Huang, Q., Wu, L.J., Tashiro, S., Gao, H.Y., Onodera, S., Ikejima, T., (+)-Catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest. J Pharmacol Sci 98 (2005), 16–24.
109. [109] D'Amours, D., Jackson, S.P., The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol 3 (2002), 317–327.
110. [110] Dumon-Jones, V., Frappart, P.O., Tong, W.M., Sajithlal, G., Hulla, W., Schmid, G., et al. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res 63 (2003), 7263–7269.
111. [111] Zhu, J., Petersen, S., Tessarollo, L., Nussenzweig, A., Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol 11 (2001), 105–109.
112. [112] Huang, D.R., Wang, J., Kivisakk, P., Rollins, B.J., Ransohoff, R.M., Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 193 (2001), 713–726.
113. [113] El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C., et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13 (2007), 432–438.
114. [114] Bellamy, T.C., Interactions between Purkinje neurones and Bergmann glia. Cerebellum 5 (2006), 116–126.
115. [115] Sudarov, A., Joyner, A.L., Cerebellum morphogenesis: the foliation pattern is orchestrated by multi-cellular anchoring centers. Neural Dev, 2, 2007, 26.
116. [116] Colon-Ramos, D.A., Shen, K., Cellular conductors: glial cells as guideposts during neural circuit development. PLoS Biol, 6, 2008, e112.
117. [117] Chung, W.S., Clarke, L.E., Wang, G.X., Stafford, B.K., Sher, A., Chakraborty, C., et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504 (2013), 394–400.
118. [118] Verkhratsky, A., Nedergaard, M., Astroglial cradle in the life of the synapse. Philos Trans R Soc Lond B Biol Sci, 369, 2014, 20130595.
119. [119] Verkhratsky, A., Nedergaard, M., Hertz, L., Why are astrocytes important?. Neurochem Res 40 (2015), 389–401.
120. [120] Seifert, G., Schilling, K., Steinhauser, C., Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7 (2006), 194–206.